INTRODUCTION
The interplay between thyroid gland and the kidney in each other's functions is known for ages. 1 The hormones from thyroid gland influence the functions of kidney, both during embryonic development and in the mature condition. It can be directly affected by glomerular function, tubular secretory and absorptive capacities, electrolyte, and water homeostasis, or in partly mediated by thyroid hormone-induced cardiovascular changes. As a consequence, in both hypo-and hyperfunctioning thyroid gland, there are alterations in clinically important renal parameters, such as GFR, urinary ACR, and markers of tubular function. 2, 3 Hypothyroidism is associated with reduction in GFR and increase in serum creatinine in more than half of the adults, even in subclinical hypothyroidism cases. There is also prominent hyponatremia. These changes normalize with onset of levothyroxine therapy. 4 The prevalence and pattern of thyroid disorders depends on sex, age, ethnic, and geographical factors and especially on iodine intake. 5 Normally daily requirement of iodine is met by a well-balanced diet and drinking water except in hilly areas and Terai regions. 6 In such regions like sub-Himalayan Terai regions, for altered geographical scenario, even supplemented iodine may not be sufficient to fulfil the need of the residing population. 7, 8 Thus the prevalence of thyroid dysfunctions, especially hypothyroidism, is very high here. 9 In light of the above facts, the present study attempts to correlate the effects of thyroid hormones on renal functions more precisely in a population with greater risk of developing hypothyroidism, i.e., in Darjeeling District of West Bengal. In this institution-based observational study, an attempt has been made to explore the alterations in renal function parameters, namely, serum creatinine, serum urea, urinary ACR, and eGFR among drug naïve primary hypothyroid patients, hypothyroid patients under treatment for more than 2 months, and age-and IJMB sex-matched control group, and also to correlate renal function parameters with serum TSH and serum-free thyroid (free T4) values among patients with primary hypothyroidism.
The observation of this study may help to take necessary steps in patients with thyroid dysfunction to prevent premature development of nephropathy and can also make the clinicians to think about thyroid dysfunction in patients with unexplained abnormal renal function.
STUDY METHODOLOGY
This institution-based observational study with mixed design 10 After having proper consent, using semi-structure questionnaires the particulars of participants, including height, weight, family history, etc., are taken along with blood and urine samples for the study. The values of the parameters under study, viz., thyroid hormonal status (serum TSH and free T4), serum creatinine, serum urea, and eGFR and ACR values have been collected and sorted. Estimated GFR has been calculated by four-variable MDRD study equation and the CKD-EPI equation. These equations are the most widely used IDMS traceable equations for estimating GFR in patients more than 18 years and over. Both the equations include variables for age, gender, and race and have been proven superior to Cockcroft Gault creatinine clearance equation. [12] [13] [14] Random urine samples are processed to measure urine microalbumin and urinary creatinine, to determine ACR. where sCr is serum creatinine in mg/dL.
CKD-EPI eGFR Calculator
where sCr is serum creatinine in mg/dL, κ is 0.7 for females and 0.9 for males, α is -0.329 for females and -0.411 for males, min indicates the minimum of sCr/κ or 1, and max indicates the maximum of sCr/κ or 1.
RESULTS
Data collected from 132 individuals are processed and analyzed with the help of statistical software Statistical Package for the Social Sciences (version 20) and Microsoft Office Excel 2010. In the total study population, 25 to 34 years age group consists of 44.67% population, 30.67% fall into 35 to 44 years age group, and the rest into 45 to 55 years age group. About 34% of the studied individuals are males and 66% of them are females. Using chi-square test, it was found that the population with thyroid disorders (total 88 individuals out of 132) is having a significant female preponderance in the study (p < 0.05).
The control group is having TSH mean value in normal range, i.e., 1.54 ± 1.16 µIU/mL with the drug naïve primary hypothyroid patients having mean TSH 18.54 ± 9.29 µIU/mL and primary hypothyroid patients on treatment having 3.76 ± 1.61 µIU/mL. The descriptive statistical data of other study parameters are arranged in Table 1 .
Using the one-way analysis of variance test, it has been seen that there are overall differences in mean values of study parameters, like serum creatinine, serum urea, ACR, and eGFR, in the chosen study groups. Further post hoc tests with Bonferroni correction has been done to isolate which group specifically differed from the others and how much significant is that, regarding a specific parameter ( Table 2 ).
Attaining that there are alterations in renal function in various study groups, an attempt has been made to find possible association between serum TSH and free T4 values with renal function parameters among control group, patients with primary hypothyroidism and primary hyperthyroidism as a whole, and by Pearson's correlation analysis (Tables 3 and 4) . Pearson correlation analysis shows that serum creatinine, serum urea, and urinary ACR are positively correlated with serum TSH value among patients with primary hypothyroidism (n = 88) regardless of the treatment status. Moreover, eGFR values are negatively correlated with serum TSH values among them.
Regarding serum free T4 values, serum creatinine, serum urea, and ACR are negatively correlated with it, among patients with primary hypothyroidism (n = 88) regardless of the treatment status. Here the eGFR values are positively correlated with free T4 among them (Graphs 1 to 4).
DISCUSSION
Thyroid hormones have effect on nearly every organ system of the human body, for kidney it is no exception. Since the period of embryogenesis, they are involved in general tissue growth as well as glomerular filtration, tubular functions, and electrolyte handling of kidney. 15, 16 In the present study, the alteration in renal function has been observed among the patients with thyroid disorders with some prefixed inclusion and exclusion criteria at North Bengal Medical College & Hospital, which is having a catchment area with higher prevalence of thyroid disorders. The entire study population has been divided into three categories. Those are newly diagnosed drug naïve primary hypothyroid patients, patients under treatment for more than 2 months for primary hypothyroidism, and a healthy control group with euthyroid status. For this purpose parameters like serum creatinine, serum urea, urinary ACR, and eGFR are explored among them.
To segregate the population with thyroid disorders, serum TSH > 4.2 µIU/mL is considered as hypothyroidism. It has been seen that the control group (n = 44) is having mean serum TSH (1.54 ± 1.16 µIU/mL) and serum free T4 (1.29 ± 0.17 ng/dL). Comparing patients with newly diagnosed drug naïve primary hypothyroidism and primary hypothyroidism patients on treatment, significant mean difference is observed for both serum TSH (18.74 ± 9.29 vs 3.76 ± 1.61 µIU/mL) and serum free T4 (0.78 ± 0.23 vs 1.25 ± 0.19 ng/dL), with a significance level of p < 0.001 for both the occasions.
A large decrease in GFR is associated with slight increases in the serum creatinine concentration within the typical reference range (0.6-1.2 mg/dL). A 60-year-old white woman with a serum creatinine level of 1 mg/dL, which is well within the typical reference range, has an eGFR of only 57 mL/min per 1.73 m 2 , whereas the same creatinine concentration in a 20-year-old AfricanAmerican male is consistent with normal renal function. Thus to better estimate the GFR, which is widely considered to be the most useful index of overall renal function, it has become customary to use equations that incorporate serum creatinine with other parameters. The most widely used of these equations in current practice is the four-parameter MDRD equation that incorporates serum creatinine, age, gender, and ethnic group (African American or not African American). The more recent CKD-EPI equation, which uses the same four parameters, is beginning to replace the MDRD equation. For clinical laboratory practice, it is recommended to report the eGFR along with creatinine measurements in adults (Graph 5). This addition provides more useful information than serum creatinine value alone. 17 Elevation of serum creatinine levels along with the reduction in GFR and renal plasma flow is found to be associated with hypothyroidism. The GFR can be reduced up to 40% in hypothyroid humans 2, 18, 19 just as predicted as experiments on animal model. 20, 21 This declining trend of GFR is corrected as soon as the hormone replacement for hypothyroidism has been started. This can only be possible if the changes in renal function do not cause permanent histological damage.
2,21
The decrease in GFR has several causes: • Hypothyroidism is associated with decreased cardiac output and circulating volume, impaired activity of the renin-angiotensin-aldosterone system, and a decreased atrial natriuretic factor level, 19, 22 which could lead to decreased renal perfusion.
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• The glomerular surface area can be decreased by growth retardation in renal parenchyma.
• A filtrate overload caused by deficient sodium and water reabsorption in the proximal tubule could lead to an adaptive preglomerular vasoconstriction.
• Renal expression of the chloride channels is decreased in hypothyroid rats. So when there is increased chloride load, sensed in the distal tubules, the tubuloglomerular feedback mechanism decreases GFR.
• Finally, hypothyroidism causes a decrease in insulinlike growth factor 1 (IGF-1). However, in response to thyroxin replacement, the IGF-1 is increased, along with the vascular endothelial growth factor (VEGF). The IGF-1 is known to increase creatinine clearance in humans and VEGF increases the activity of nitric oxide synthase, thereby improving the relaxing capacity of the renal vasculature. Hence, both IGF-1 and VEGF could influence renal blood flow and GFR in hypothyroidism before and after thyroxin replacement. 15, 23 In the present study, eGFR is considered as an important yardstick for assessment of renal function. Estimated GFR has been calculated with the help of two different formulas using serum creatinine values, age, gender, and ethnic group, i.e., CKD-EPI eGFR and four-variable MDRD eGFR. As thyroid disorder alters metabolism of cystatin C, cystatin C-based equation has not been incorporated here. 24, 25 Using both the equations, eGFR was observed to be significantly low (p < 0. In primary hypothyroidism also, reversible increase in GFR was observed following thyroxine treatment.
2,4,16
The HUNT study used only four-variable MDRD study equation to estimate GFR. 26 In the present study, the findings are in harmony with the observations of Åsvold et al 26 Values of serum creatinine differed significantly among patients with newly diagnosed primary hypothyroidism (1.18 ± 0.13 mg/dL) from control group (0.79 ± 0.09 mg/ dL) and those on treatment for primary hypothyroidism for more than 2 months (0.89 ± 0.11 mg/dL) at a significance level of p < 0.001 on both the occasions. In a hospital-based study conducted by Arora et al, 29 significantly raised serum creatinine values have been reported among patients with hypothyroidism compared with euthyroid controls (p < 0.001). They observed a group of overt hypothyroid patients (n = 46) for 6 weeks with uninterrupted thyroid hormonal replacement and found that posttreatment serum creatinine level lowered significantly compared with pretreatment status (p = 0.005). In their longitudinal study on changes in renal function in primary hypothyroidism, Montenegro et al 21 observed significant alteration in serum creatinine level among pretreatment and posttreatment condition of hypothyroid patients (1.16 ± 0.04 vs 0.87 ± 0.02 mg/dL, p < 0.05). This shows the reversible alteration of serum creatinine in primary hypothyroidism. In the present study, the longitudinal follow-up was not done for primary hypothyroid patients. Still patients with primary hypothyroidism under treatment were found to have significantly low serum creatinine level compared with newly diagnosed drug naïve patients (p < 0.001). As the possible confounding factors have been eliminated beforehand, these data can be corroborated with the observations of Montenegro et al 21 and Arora et al. 29 So far, creatinine-based equation has been used to evaluate GFR or eGFR in this study. But it can be argued that serum creatinine-based equations may not reflect the true GFR alteration in thyroid dysfunction, as the creatinine values in hypothyroidism patients are changing with the course of disease. Tsuda et al 30 in their recent study about intrarenal hemodynamic parameters demonstrated that the high serum TSH, even within higher normal range, was significantly correlated with reduction in GFR, renal plasma flow, and renal blood flow, by simultaneous measurements of plasma clearance of para-aminohippurate and inulin. So, alteration in serum creatinine, serum urea, and eGFR in patients with hypothyroidism before and after hormonal replacement is actually a reflection of alteration in GFR among them. Lippi et al studied on relationship between thyroid status and renal function in a general population of unselected outpatients (n = 13,383). They also found that when compared with euthyroid subjects, those with TSH < 0.2 µIU/mL and >2.5 µIU/mL had increased and decreased eGFR respectively. 31 In all the studied groups, serum urea was found to be in the normal laboratory range. Still statistically significant alteration (p < 0.001) has been found while comparing newly diagnosed drug naïve primary hypothyroidism (24.25 ± 6.79 mg/dL) with control group (18.31 ± 2.44 mg/ dL) and those are on treatment for primary hypothyroidism for more than 2 months (16.66 ± 3.4 mg/dL). This can be explained by the alteration in GFR in hypothyroidism which is reversible upon initiation of hormone replacement therapy. thyroid hormones and microalbuminuria in Chinese population (n = 3346). The prevalence of microalbuminuria decreased according to free T3 quartiles (p for trend = 0.0005). This study was the first to report an independent association between thyroid hormones concentration and microalbuminuria in a large population. In the present study, newly diagnosed drug naïve primary hypothyroid patients are having mean ACR 115.9 ± 30.94 mg/ gm (in the range of microalbuminuria). It was observed that there is statistically significant decrease in ACR comparing primary hypothyroidism patients under treatment for more than 2 months with those are newly diagnosed (ACR 46.96 ± 17.24 vs 115.9 ± 30.94 mg/gm, p < 0.001). Even patients on treatment for hypothyroidism for more than 2 months are having microalbuminuria just above the normal range (46.96 ± 17.24 mg/gm for ACR), and that also statistically significant compared with euthyroid control (p < 0.001). So these data indicate microalbuminuria in primary hypothyroidism and suggest its reversibility on treatment.
It has been suggested that autoimmune thyroid disease may lead to endothelial dysfunction due to deposition of immune-complexes [especially antithyroid peroxidase (TPO) antibody] in the renal glomeruli. So hypothyroidism associated with anti-TPO +ve status is more likely to develop microalbuminuria and is associated with reduced GFR. 4, 33 But in the HUNT study, the association with eGFR was found to be roughly similar for hypothyroidism with and without TPO antibodies. 26 Also, the data provided by Zhou et al 32 showed that the link with microalbuminuria was roughly similar for thyroid hormones with or without anti-TPO antibody status (p = 0.93). This suggests that immunological damage to the kidney caused by autoimmunity is not a likely explanation for the association of thyroid hormonal status with reduced eGFR or microalbuminuria. The effects of thyroid hormones on alteration of renal functions might be independent of thyroid autoimmunity. However, this was beyond the scope of the present study to establish thyroid autoimmunity as an etiology for alteration in renal function, and further longitudinal studies are needed to establish that. Åsvold et al 26 showed that TSH within the reference range was negatively associated with eGFR (p for trend <0.001). 1 µIU/mL higher TSH was associated with 1.9% lower eGFR, and there was no appreciable difference between women and men. Pearson correlation tests are performed to explore the correlation with serum TSH and free T4 with renal function parameters in the present study. It has been seen that among all the patients with hypothyroidism (n = 88), serum TSH is negatively correlated with eGFR measured both by MDRD formula and CKD-EPI formula (p < 0.001). Free T4 is positively correlated with eGFR (p < 0.001). On the contrary, serum creatinine, serum urea, and ACR are positively correlated with serum TSH (p < 0.001) and negatively with free T4 (p < 0.001). While conducting a cross-sectional study on Indian population, Saini et al 34 examined 47 patients with overt and 77 patients with subclinical hypothyroidism and found serum TSH is positively correlating with serum creatinine values among them (p < 0.05). In a study on "correlation of thyroid dysfunction with serum creatinine," Attaullah et al 35 observed that among hypothyroid subjects (n = 191) serum creatinine is positively correlating with TSH and negatively with serum T4 (p < 0.001 on both the occasions). They also observed that in hyperthyroid patients (n = 195) serum creatinine is negatively correlated with T4 (p < 0.001). Montenegro et al 21 failed to establish any correlation between renal function and serum concentrations of T4 or TSH in their study. They have dealt with relatively small sample size (n = 41), which could possibly be the reason behind such findings. In both simple and multivariate-adjusted linear regression analyses, free T3 levels were found to be negatively and significantly associated with ACR (p < 0.05), in the study by Zhou et al. 32 Thus, it has been seen so far in the present study that both hypothyroidism and hyperthyroidism associate with significant alteration in kidney function. These effects are the results of direct renal actions, as well as systemic hemodynamic, metabolic, and cardiovascular effects, exerted by thyroid hormones. Fortunately, most of the renal manifestations of thyroid disorders, which are clinically more significant with hypothyroidism, are reversible with treatment. These could only be possible if the changes in renal function are not associated with any sort of permanent histological damage. However, it has recently been reported by Elgadi et al 36 that kidney function recovers slowly in hypothyroid children, and sometimes partially, after the introduction of replacement with levothyroxine. The long-term clinical implications of these findings are still unknown.
CONCLUSION
In the present institution-based observational study, most of the renal manifestations are found to be significant for drug naïve primary hypothyroid patients. It has been seen that these patients have lower than normal eGFR, elevated serum creatinine, serum urea, and microalbuminuria, compared with euthyroid controls. Fortunately, the alteration in renal function has been found to be reversible while observing primary hypothyroid patients under treatment for more than 2 months. It has also been seen that TSH values are negatively correlated with eGFR and positively correlated with microalbuminuria among primary hypothyroid patients regardless of the treatment status. For free T4, these relationships are just the opposite of serum TSH among them. Thus with these observations, it can be suggested that patients with unexplained abnormal renal function should be screened for thyroid disorders, especially for primary hypothyroidism. But it is still not certain about the possible outcome of the deranged renal function among the untreated patients with hypothyroidism in the long run. As microalbuminuria is recognized as a predictor of adverse renal outcome even in nondiabetic subjects, the possibility of nephropathy in near future should not be turned down for untreated overt hypothyroid patients. Thus, it should be recommended to check for alteration in renal functions among untreated hypothyroid patients and take necessary actions in the form of hormone replacement therapy to abort any possibility of future nephropathy.
